Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Fremont, Calif-based ophthalmic information system developer Visunex Medical said it won FDA 510(k) clearance for its PanoCam Pro Wide-field Imaging System designed for imaging newborn infants.
The PanoCam Pro is a wireless imaging system deisgned to help detect external, anterior and posterior segment vision disorders in newborns, which the company says may have long term effects on chilren. Read more
Japan’s Asahi Kasei Corp., which in 2012 paid $2.3 billion to acquire Zoll Medical, is shuffling the deck at the resuscitation device maker.
Former CEO Rick Packer, who led Zoll for 13 years before overseeing the merger with Asahi Kasei, was promoted to primary executive officer and charged with building the healthcare business into “a 3rd pillar” of the Asahi Kasei Group. The conglomerate, which is also in the construction and chemical & fiber businesses, said the healthcare unit will consist of Zoll, Asahi Kasei Pharma, Asahi Kasei Medical and “future global healthcare companies.” Read more
Medtronic said today that it enrolled the 1st European patient in a huge, real-world study of the SuperDimension lung device it acquired along with Covidien early last year.
The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm post-market study also aims to measure how often doctors use the system to obtain biopsies from surrounding lymph nodes and place markers to guide future procedures, Medtronic said. Read more